rs387906359
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000492.4(CFTR):c.2423_2424dupAT(p.Ser809IlefsTer13) variant causes a frameshift change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000492.4 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CFTR | NM_000492.4 | c.2423_2424dupAT | p.Ser809IlefsTer13 | frameshift_variant | Exon 14 of 27 | ENST00000003084.11 | NP_000483.3 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Cystic fibrosis Pathogenic:5
Variant summary: CFTR c.2423_2424dupAT (p.Ser809IlefsX13) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory. This variant is also reported as legacy name 2556insAT, and can be referred to as c.2424_2425dupAT, c.2421_2422dupAT, and c.2422_2423insAT. The variant was absent in 179966 control chromosomes (gnomAD). c.2423_2424dupAT has been reported in the literature and in CF patient databases in individuals affected with Cystic Fibrosis (e.g. White_1990, CFTR2 database). These data indicate that the variant is likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Three submitters have provided clinical-significance assessments for this variant to ClinVar after 2014 and all classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. -
- -
- -
For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in CFTR are known to be pathogenic (PMID: 1695717, 7691345, 9725922). This variant has been observed in individual(s) with clinical features of cystic fibrosis (CF) (PMID: 1691449). This variant is also known as CFIns2566 and 2556insAT. This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Ser809Ilefs*13) in the CFTR gene. It is expected to result in an absent or disrupted protein product. -
The c.2423_2424dupAT pathogenic mutation (also known as CFTR ins2556insAT, c.2424_2425dupAT, c.2421_2422dupAT, and c.2422_2423insAT) is located in coding exon 14 of the CFTR gene and results from a duplication of AT at nucleotide position 2423, causing a translational frameshift with a predicted alternate stop codon (p.S809Ifs*13). This alteration was described in an individual with features of cystic fibrosis or a CFTR-related disorder (White MB et al. Nature, 1990 Apr;344:665-7). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at